Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
1,007 trades
$2.1B in total
Open-market sales
1,283 trades
$2.7B in total
Insiders filing
578 insiders
Last 7 days
Trade type
Pres. & Chief Med. & Dev. Off
Senti Biosciences HoldingsSNTI
Open-market sale25/02/04–25/02/0625/02/061,479 sh2 trades$4.11avg.$6,074.13−14.6%
CEO
Senti Biosciences HoldingsSNTI
Open-market sale25/02/04–25/02/0625/02/064,467 sh2 trades$4.11avg.$18,338.74−5.2%